Influence of Sex and Hormone Status on Circulating Natriuretic Peptides

被引:142
|
作者
Lam, Carolyn S. P. [1 ,6 ,7 ,8 ]
Cheng, Susan [1 ,2 ]
Choong, Karen [3 ,4 ]
Larson, Martin G. [1 ,5 ]
Murabito, Joanne M. [1 ]
Newton-Cheh, Christopher [1 ,2 ]
Bhasin, Shalender [3 ,4 ]
McCabe, Elizabeth L. [1 ,2 ]
Miller, Karen K. [2 ]
Redfield, Margaret M. [6 ]
Vasan, Ramachandran S. [1 ,7 ,8 ]
Coviello, Andrea D. [1 ,3 ,4 ,7 ,8 ]
Wang, Thomas J. [1 ,2 ]
机构
[1] Framingham Heart Dis Epidemiol Study, Framingham, MA USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[3] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA
[4] Boston Med Ctr, Boston, MA USA
[5] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[6] Mayo Clin, Rochester, MN USA
[7] Boston Univ, Sch Med, Prevent Med Sect, Boston, MA 02118 USA
[8] Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA
关键词
hormones; natriuretic peptides; sex; CARDIAC ENDOCRINE FUNCTION; TANDEM MASS-SPECTROMETRY; CORONARY HEART-DISEASE; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; BINDING GLOBULIN; MENSTRUAL-CYCLE; FREE TESTOSTERONE; FOLLICULAR PHASE; RISK-FACTORS;
D O I
10.1016/j.jacc.2011.03.042
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to assess the relationship between sex hormones and natriuretic peptide levels in community-based adults. Background Women have higher circulating natriuretic peptide concentrations than men, but the mechanisms for these sex-related differences and the impact of hormone therapy are unclear. Experimental studies suggest that androgens may suppress natriuretic peptide secretion. Methods We measured N-terminal pro-B-type natriuretic peptide (NT-proBNP), total testosterone, and sex hormone-binding globulin plasma levels in 4,056 men and women (mean age 40 +/- 9 years) from the Framingham Heart Study Third-Generation cohort. Sex/hormone status was grouped as: 1) men; 2) post-menopausal women not receiving hormone replacement therapy; 3) pre-menopausal women not receiving hormonal contraceptives; 4) post-menopausal women receiving hormone replacement therapy; and 5) pre-menopausal women receiving hormonal contraceptives. Results Circulating NT-proBNP levels were associated with sex/hormone status (overall p < 0.0001). Men had lower NT-proBNP levels than women of all menopause or hormone groups, and women receiving hormonal contraceptives had higher NT-proBNP levels than women who were not receiving hormone therapy (all p < 0.0001). These relationships remained significant after adjusting for age, body mass index, and cardiovascular risk factors. Across sex/hormone status groups, free testosterone (FT) levels decreased and sex hormone-binding globulin levels increased in tandem with increasing NT-proBNP levels. In sex-specific analyses, NT-proBNP levels decreased across increasing quartiles of FT in men (p for trend < 0.01) and women (p for trend < 0.0001). Adjustment for FT markedly attenuated the association between sex/hormone status and NT-proBNP concentrations. Conclusions These findings suggest that lower levels of circulating androgens and the potentiating effect of exogenous female hormone therapy contribute to the higher circulating NT-proBNP concentrations in women. (J Am Coll Cardiol 2011;58:618-26) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:618 / 626
页数:9
相关论文
共 50 条
  • [21] THE EFFECTS OF ANGIOTENSIN-II ON CIRCULATING LEVELS OF NATRIURETIC PEPTIDES
    CARGILL, RI
    COUTIE, WJ
    LIPWORTH, BJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (02) : 139 - 142
  • [22] Relation of Visceral Adiposity to Circulating Natriuretic Peptides in Ambulatory Individuals
    Cheng, Susan
    Fox, Caroline S.
    Larson, Martin G.
    Massaro, Joseph M.
    McCabe, Elizabeth L.
    Khan, Abigail May
    Levy, Daniel
    Hoffmann, Udo
    O'Donnell, Christopher J.
    Miller, Karen K.
    Newton-Cheh, Christopher
    Coviello, Andrea D.
    Bhasin, Shalender
    Vasan, Ramachandran S.
    Wang, Thomas J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (07): : 979 - 984
  • [23] NORMALIZATION OF CIRCULATING ATRIAL NATRIURETIC PEPTIDES IN CARDIAC TRANSPLANT RECIPIENTS
    WESTON, MW
    CINTRON, GB
    GIORDANO, AT
    VESELY, DL
    AMERICAN HEART JOURNAL, 1994, 127 (01) : 129 - 142
  • [24] Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension
    Kaiser, Ralf
    Grotemeyer, Katharina
    Lepper, Philipp
    Stokes, Caroline
    Bals, Robert
    Wilkens, Heinrike
    RESPIRATORY MEDICINE, 2015, 109 (09) : 1213 - 1223
  • [25] MOLECULAR-SPECIES OF CIRCULATING ATRIAL NATRIURETIC PEPTIDES AND THEIR METABOLITES
    GOWER, WR
    CHIOU, S
    SKOLNICK, KA
    VESELY, DL
    CLINICAL RESEARCH, 1994, 42 (02): : A342 - A342
  • [26] Diagnostic potential of circulating natriuretic peptides in chronic kidney disease
    Mark, PB
    Stewart, GA
    Gansevoort, RT
    Petrie, CJ
    McDonagh, TA
    Dargie, HJ
    Rodger, RSC
    Jardine, AG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (02) : 402 - 410
  • [27] PURIFICATION AND STRUCTURE OF CIRCULATING ATRIAL NATRIURETIC FACTOR PEPTIDES IN MAN
    YANDLE, TG
    CROZIER, IG
    NICHOLLS, MG
    ESPINER, EA
    CARNE, A
    BRENNAN, SO
    NEW ZEALAND MEDICAL JOURNAL, 1987, 100 (837) : 752 - 752
  • [28] Prospective evaluation of the Batista procedure with circulating atrial natriuretic peptides
    Weston, MW
    Vijayangar, R
    Overton, RM
    Vesely, DL
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 74 (2-3) : 145 - 152
  • [29] The influence of natriuretic peptides on anxiety in rats.
    Jahn, H
    Montkowski, A
    Wiedemann, K
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 423 - 423
  • [30] ATRIAL NATRIURETIC FACTOR - A CIRCULATING HORMONE STIMULATED BY VOLUME LOADING
    LANG, RE
    THOLKEN, H
    GANTEN, D
    LUFT, FC
    RUSKOAHO, H
    UNGER, T
    NATURE, 1985, 314 (6008) : 264 - 266